You are here

Pharma firm Alexion to buy peer Synageva


ALEXION Pharmaceuticals Inc on Wednesday said it agreed to buy Synageva BioPharma Corp for US$8.4 billion, more than twice its market value, to expand its offering of potentially high-priced medicines for rare diseases.

Alexion's willingness to pay an eye-popping premium for